CMV seropositivity is a potential novel risk factor for severe COVID-19 in non-geriatric patients

• Simone Weber ,

  Contributed equally to this work with: Simone Weber, Victoria Kehl

  Roles Conceptualization, Formal analysis, Investigation, Writing – original draft

  Affiliation Institute for Medical Microbiology, Immunology and Hygiene, Technical University of Munich, Munich, Germany

  ⨯
• Victoria Kehl ,

  Contributed equally to this work with: Simone Weber, Victoria Kehl

  Roles Formal analysis, Investigation, Methodology, Writing – original draft

  Affiliation Institute for AI and Informatics in Medicine, School of Medicine, Technical University of Munich, Munich, Germany

  ⨯
• Johanna Erber,

  Roles Investigation, Resources

  Affiliations Department of Internal Medicine II, University Hospital Rechts Der Isar, School of Medicine, Technical University of Munich, Munich, Germany, German Center for Infection Research (DZIF), Munich, Germany

  ⨯
• Karolin I. Wagner,

  Roles Resources

  Affiliation Institute for Medical Microbiology, Immunology and Hygiene, Technical University of Munich, Munich, Germany

  ⨯
• Ana-Marija Jetzlsperger,

  Roles Investigation, Resources

  Affiliation Institute of Virology, School of Medicine, Technical University of Munich, Munich, Germany

  ⨯
• Teresa Burrell,

  Roles Resources

  Affiliation Institute for Medical Microbiology, Immunology and Hygiene, Technical University of Munich, Munich, Germany

  ⨯
• Kilian Schober,

  Roles Resources

  Affiliation Mikrobiologisches Institut–Klinische Mikrobiologie, Immunologie und Hygiene, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität (FAU) Erlangen-Nürnberg, Erlangen, Germany

  ⨯
• Philipp Schommers,

  Roles Resources

  Affiliations Medical Faculty and University Hospital Cologne, Department I of Internal Medicine, University of Cologne, Cologne, Germany, German Center for Infection Research (DZIF), Bonn-Cologne, Germany

  ⨯
• Max Augustin,

  Roles Resources

  Affiliations Medical Faculty and University Hospital Cologne, Department I of Internal Medicine, University of Cologne, Cologne, Germany, German Center for Infection Research (DZIF), Bonn-Cologne, Germany

  ⨯
• Claudia S. Crowell,

  Roles Investigation

  Affiliations Institute for Medical Microbiology, Immunology and Hygiene, Technical University of Munich, Munich, Germany, German Center for Infection Research (DZIF), Munich, Germany

  ⨯
• Markus Gerhard,

  Roles Funding acquisition, Resources

  Affiliations Institute for Medical Microbiology, Immunology and Hygiene, Technical University of Munich, Munich, Germany, German Center for Infection Research (DZIF), Munich, Germany

  ⨯
• Christof Winter,

  Roles Investigation, Resources

  Affiliation Institute of Clinicl Chemistry and Pathobiochemistry, School of Medicine, Technical University of Munich, Munich, Germany

  https://orcid.org/0000-0002-0253-9056

  ⨯
• Andreas Moosmann,

  Roles Resources

  Affiliations German Center for Infection Research (DZIF), Munich, Germany, Department of Medicine III, University Hospital, LMU Munich, Munich, Germany

  ⨯
• Christoph D. Spinner,

  Roles Investigation, Resources

  Affiliations Department of Internal Medicine II, University Hospital Rechts Der Isar, School of Medicine, Technical University of Munich, Munich, Germany, German Center for Infection Research (DZIF), Munich, Germany

  https://orcid.org/0000-0002-3875-5367

  ⨯
• Ulrike Protzer,

  Roles Investigation, Resources

  Affiliation Institute of Virology, School of Medicine, Technical University of Munich, Munich, Germany

  ⨯
• Dieter Hoffmann,

  Roles Investigation, Methodology

  Affiliation Institute of Virology, School of Medicine, Technical University of Munich, Munich, Germany

  ⨯
• Elvira D’Ippolito ,

  Roles Conceptualization, Project administration, Supervision, Writing – review & editing

  ¶‡ These authors also contributed equally to this work.

  Affiliation Institute for Medical Microbiology, Immunology and Hygiene, Technical University of Munich, Munich, Germany

  ⨯
•  [ ... ],
• Dirk H. Busch

  Roles Conceptualization, Funding acquisition, Supervision, Writing – original draft

  * E-mail: dirk.busch@tum.de

  ¶‡ These authors also contributed equally to this work.

  Affiliations Institute for Medical Microbiology, Immunology and Hygiene, Technical University of Munich, Munich, Germany, German Center for Infection Research (DZIF), Munich, Germany

  https://orcid.org/0000-0001-8713-093X

  ⨯
• [ view all ]
• [ view less ]